Recent News for FGEN - FibroGen, Inc

Date Title
May 27 FibroGen to Present at Upcoming Investor Conferences
May 21 The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
May 21 European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat
May 21 EMA accepts Astellas application for roxadustat for CKD anemia
May 21 European Medicines Agency Accepts Astellas' Marketing Authorization Application for Roxadustat
May 11 FibroGen, Inc. (NASDAQ:FGEN) Analysts Are Cutting Their Estimates: Here's What You Need To Know
May 9 FibroGen Inc (FGEN) Q1 2020 Earnings Call Transcript
May 9 FibroGen, Inc. (FGEN) CEO Enrique Conterno on Q1 2020 Results - Earnings Call Transcript
May 8 Edited Transcript of FGEN earnings conference call or presentation 7-May-20 9:00pm GMT
May 8 FibroGen to Present at Bank of America Securities 2020 Health Care Conference
May 8 FibroGen (FGEN) Reports Q1 Loss, Lags Revenue Estimates
May 7 FibroGen EPS misses by $0.61, misses on revenue
May 7 FibroGen Reports First Quarter 2020 Financial Results
May 7 Akebia Shares Climb on Positive Anemia Drug Study Results
May 6 FibroGen Q1 2020 Earnings Preview
May 6 Why FibroGen (FGEN) Might Surprise This Earnings Season
May 3 How Does Investing In FibroGen, Inc. (NASDAQ:FGEN) Impact The Volatility Of Your Portfolio?
May 3 The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
May 1 Benzinga's Top Upgrades, Downgrades For May 1, 2020
Apr 27 Benzinga's Top Upgrades, Downgrades For April 27, 2020
Apr 27 Citi bullish on reference labs in premarket analyst action
Apr 24 FibroGen To Report First Quarter 2020 Financial Results
Apr 21 Keros Therapeutics Shares Climb 70% After First Post-Covid-19 Biotech IPO
Apr 20 UK court rules out FibroGen's patents
Apr 20 FibroGen Reports UK Court Ruling

Back to the Main FGEN Page...